In this section of the BIO Europe Tradeshow Site, you'll find news releases from our exhibitors. The releases are listed in chronological order and are archived by month and year.
-
Mar 8, 2018
Treatment with TyrNovo's NT219 in combination with targeted cancer drugs, as well as chemotherapy and immuno-oncology therapies, prevented acquired resistance and reversed resistance of colon, lung and head-and-neck cancers in patient-derived xenograft models
-
-
-
-
-
-
-
